AFP and neoplasm: In subgroup analysis of patients with RI undergoing curative treatment, age older than 65 years (HR: 1.385, p = 0.026), serum AFP ≥20 ng/mL (HR: 1.697, p < 0.001), tumor size >3 cm (HR: 1.553, p < 0.001), vascular invasion (HR: 2.321, p < 0.001), distant metastasis (HR: 2.335, p < 0.001), performance status 1–2 (HR: 1.488, p < 0.001), performance status 3–4 (HR: 1.958, p < 0.001), ALBI grade 2 (HR: 1.682, p < 0.001), and ALBI grade 3 (HR: 7.115, p < 0.001) were associated with poor survival in multivariate analysis (Table 4).